Myron S. Czuczman
2022
In 2022, Myron S. Czuczman earned a total compensation of $887.8K as Chief Medical Officer and Executive Vice President at Citius Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $336,929 |
| Salary | $400,000 |
| Other | $917 |
| Total | $887,846 |
Czuczman received $400K in salary, accounting for 45% of the total pay in 2022.
Czuczman also received $150K in non-equity incentive plan, $336.9K in option awards and $917 in other compensation.
Rankings
In 2022, Myron S. Czuczman's compensation ranked 3,291st out of 5,756 executives tracked by ExecPay. In other words, Czuczman earned more than 42.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,291 out of 5,756 | 43rd |
Division Manufacturing | 1,853 out of 3,133 | 41st |
Major group Chemicals And Allied Products | 882 out of 1,419 | 38th |
Industry group Drugs | 825 out of 1,320 | 38th |
Industry Pharmaceutical Preparations | 599 out of 966 | 38th |
Source: SEC filing on December 22, 2022.
Czuczman's colleagues
We found three more compensation records of executives who worked with Myron S. Czuczman at Citius Pharmaceuticals in 2022.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020